INVESTOR ALERT: Investigation of Trevena Announced by Holzer & Holzer, LLC

Holzer & Holzer, LLC is investigating whether certain statements issued by Trevena, Inc. (Trevena or the Company) (NASDAQ: TRVN) complied with federal securities laws. On October 9, 2018, the minutes from Trevenas April 28, 2016 meeting with the Food and Drug Administration (FDA) were released, which disclosed that the FDA did not agree with several aspects of Trevenas Phase 3 study for Oliceridine. The price of Trevenas stock declined following the report.

If you purchased Trevena common stock and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at [email protected] or Marshall P. Dees, Esq. at [email protected], or by toll-free telephone at (888) 508-6832 to discuss your legal rights.

Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.

Holzer & Holzer, LLC
Corey D. Holzer, Esq., 888-508-6832
(toll-free)
[email protected]

WANT TO BUILD A FINANCIAL EMPIRE?

Subscribe to the Global Banking & Finance Review Newsletter for FREE
Get Access to Exclusive Reports to Save Time & Money

By using this form you agree with the storage and handling of your data by this website. We Will Not Spam, Rent, or Sell Your Information.
All emails include an unsubscribe link. You may opt-out at any time. See our privacy policy.